Abstract
The strategy for the development of the pharmaceutical industry is closely linked to ensuring the national security of Russia. In connection with the situation caused by the spread of COVID-19, the development of this industry is of particular relevance. An analysis of the implementation of the pharmaceutical industry development program based on one of the indicators — the share of imported products in the commercial pharmaceutical market in the period from 2016 to 2021 shows that the Russian pharmaceutical industry will take a worthy place in the world market and will become a source of GDP growth.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Vestnik BIST (Bashkir Institute of Social Technologies)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
